IV PERSANTINE
LOE ApproachingNDAINJECTIONINJECTABLEPriority Review
Approved
Dec 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 17h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
IV PERSANTINE (dipyridamole) is a small-molecule injectable vasodilator approved in 1990 for diagnostic cardiac stress testing and adjunctive use in thromboembolic prevention. It works by inhibiting phosphodiesterase and increasing adenosine levels, causing coronary vasodilation to unmask myocardial ischemia during diagnostic imaging.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), suggesting downsizing commercial infrastructure and focus on cost management rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
IV PERSANTINE offers limited career growth opportunities given its approaching loss of exclusivity and minimal linked job openings (0 current postings). Roles on this product are primarily focused on maximizing remaining profitability and managing transition to post-LOE environment rather than innovation or market expansion.
Brand ManagerMedical Science Liaison
Worked on IV PERSANTINE at Boehringer Ingelheim? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.